Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal J Meropol

Showing results (211-220 of 226) with videos related to

Pageof 23
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2006
Esophageal Cancer Clinical Practice GuidelinesJaffer Ajani, Tanios Bekaii-Saab, Thomas A D'Amico, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2006
Gastric Cancer Clinical Practice GuidelinesJaffer Ajani, Tanios Bekaii-Saab, Thomas A D'Amico, et al.
Nature Communications|June 21, 2016
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancerYujun Hao, Yardena Samuels, Qingling Li, et al.
Breast Cancer Research and Treatment|July 5, 2024
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Research Square|May 15, 2024
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments ReceivedLowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2015
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment OptionsLowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2021
A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research WorkshopDaniel D Von Hoff, Gary M Clark, Charles A Coltman, et al.
Cancer Research|December 15, 2010
Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinaseArijit Chakravarty, Vaishali Shinde, Josep Tabernero, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Esophageal cancerJaffer A Ajani, James S Barthel, Tanios Bekaii-Saab, et al.
Pageof 23

Showing results (211-220 of 226) with videos related to

Sort By:
Pageof 23
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2006
Esophageal Cancer Clinical Practice GuidelinesJaffer Ajani, Tanios Bekaii-Saab, Thomas A D'Amico, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2006
Gastric Cancer Clinical Practice GuidelinesJaffer Ajani, Tanios Bekaii-Saab, Thomas A D'Amico, et al.
Nature Communications|June 21, 2016
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancerYujun Hao, Yardena Samuels, Qingling Li, et al.
Breast Cancer Research and Treatment|July 5, 2024
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Research Square|May 15, 2024
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments ReceivedLowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2015
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment OptionsLowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2021
A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research WorkshopDaniel D Von Hoff, Gary M Clark, Charles A Coltman, et al.
Cancer Research|December 15, 2010
Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinaseArijit Chakravarty, Vaishali Shinde, Josep Tabernero, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Esophageal cancerJaffer A Ajani, James S Barthel, Tanios Bekaii-Saab, et al.
Pageof 23